MOONLAKE IMMUNOTHERAPEUTICS Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- MOONLAKE IMMUNOTHERAPEUTICS payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00.
- MOONLAKE IMMUNOTHERAPEUTICS payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00.
- MOONLAKE IMMUNOTHERAPEUTICS payments for repurchase of common stock for the quarter ending 2024-06-30 was $0.00.
- MOONLAKE IMMUNOTHERAPEUTICS payments for repurchase of common stock for the quarter ending 2024-03-31 was $50.00.
- MOONLAKE IMMUNOTHERAPEUTICS payments for repurchase of common stock for fiscal 2024 was $50.00.
- MOONLAKE IMMUNOTHERAPEUTICS payments for repurchase of common stock for fiscal 2023 was $0.00.
- MOONLAKE IMMUNOTHERAPEUTICS payments for repurchase of common stock for fiscal 2022 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $50.00 10-K · filed 2025-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $50.00 derived: sum of 4 quarters · filed 2025-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $50.00 derived: sum of 4 quarters · filed 2025-02-26 |
| 2024-03-31 | $50.00 10-Q · filed 2024-05-07 | $50.00 derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 10-K · filed 2025-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $0.00 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |